vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and SouthState Bank Corp (SSB). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $661.7M, roughly 1.3× SouthState Bank Corp). SouthState Bank Corp runs the higher net margin — 34.1% vs 0.5%, a 33.6% gap on every dollar of revenue. Over the past eight quarters, SouthState Bank Corp's revenue compounded faster (37.4% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
SouthState Bank, based in Winter Haven, Florida, is an American bank and a subsidiary of SouthState Corporation, a bank holding company. As of May 26, 2025, the company had 371 branches in South Carolina, North Carolina, Georgia, Florida, Alabama, Virginia, Colorado and Texas.
ACHC vs SSB — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $661.7M |
| Net Profit | $4.5M | $225.8M |
| Gross Margin | — | — |
| Operating Margin | — | 15.1% |
| Net Margin | 0.5% | 34.1% |
| Revenue YoY | 7.5% | — |
| Net Profit YoY | -50.8% | 153.5% |
| EPS (diluted) | $0.05 | $2.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | $661.7M | ||
| Q4 25 | $821.5M | $581.1M | ||
| Q3 25 | $851.6M | $599.7M | ||
| Q2 25 | $869.2M | $577.9M | ||
| Q1 25 | $770.5M | $544.5M | ||
| Q4 24 | $774.2M | $369.8M | ||
| Q3 24 | $815.6M | $351.5M | ||
| Q2 24 | $796.0M | $350.3M |
| Q1 26 | $4.5M | $225.8M | ||
| Q4 25 | $-1.2B | $247.7M | ||
| Q3 25 | $36.2M | $246.6M | ||
| Q2 25 | $30.1M | $215.2M | ||
| Q1 25 | $8.4M | $89.1M | ||
| Q4 24 | $32.6M | $144.2M | ||
| Q3 24 | $68.1M | $143.2M | ||
| Q2 24 | $78.5M | $132.4M |
| Q1 26 | — | 15.1% | ||
| Q4 25 | -142.4% | 54.3% | ||
| Q3 25 | 4.7% | 53.6% | ||
| Q2 25 | 5.8% | 48.8% | ||
| Q1 25 | 1.7% | 22.3% | ||
| Q4 24 | 4.9% | 50.7% | ||
| Q3 24 | 12.1% | 53.1% | ||
| Q2 24 | 13.4% | 49.3% |
| Q1 26 | 0.5% | 34.1% | ||
| Q4 25 | -143.3% | 42.6% | ||
| Q3 25 | 4.3% | 41.1% | ||
| Q2 25 | 3.5% | 37.2% | ||
| Q1 25 | 1.1% | 16.4% | ||
| Q4 24 | 4.2% | 39.0% | ||
| Q3 24 | 8.4% | 40.7% | ||
| Q2 24 | 9.9% | 37.8% |
| Q1 26 | $0.05 | $2.28 | ||
| Q4 25 | $-12.98 | $2.47 | ||
| Q3 25 | $0.40 | $2.42 | ||
| Q2 25 | $0.33 | $2.11 | ||
| Q1 25 | $0.09 | $0.87 | ||
| Q4 24 | $0.36 | $1.88 | ||
| Q3 24 | $0.74 | $1.86 | ||
| Q2 24 | $0.85 | $1.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $2.9B |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $9.0B |
| Total Assets | $5.5B | $68.0B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | $2.9B | ||
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | — | ||
| Q2 25 | $131.4M | — | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | — |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | $9.0B | ||
| Q4 25 | $1.9B | $9.1B | ||
| Q3 25 | $3.1B | $9.0B | ||
| Q2 25 | $3.1B | $8.8B | ||
| Q1 25 | $3.0B | $8.6B | ||
| Q4 24 | $3.1B | $5.9B | ||
| Q3 24 | $3.0B | $5.9B | ||
| Q2 24 | $3.0B | $5.7B |
| Q1 26 | $5.5B | $68.0B | ||
| Q4 25 | $5.5B | $67.2B | ||
| Q3 25 | $6.4B | $66.0B | ||
| Q2 25 | $6.3B | $65.9B | ||
| Q1 25 | $6.1B | $65.1B | ||
| Q4 24 | $6.0B | $46.4B | ||
| Q3 24 | $5.9B | $46.1B | ||
| Q2 24 | $5.7B | $45.5B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $232.1M | ||
| Q3 25 | $73.2M | $122.4M | ||
| Q2 25 | $133.5M | $72.6M | ||
| Q1 25 | $11.5M | $-126.3M | ||
| Q4 24 | $116.7M | $354.3M | ||
| Q3 24 | $163.1M | $-246.8M | ||
| Q2 24 | $171.1M | $126.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $215.5M | ||
| Q3 25 | $-63.0M | $101.7M | ||
| Q2 25 | $-34.2M | $52.5M | ||
| Q1 25 | $-163.2M | $-139.1M | ||
| Q4 24 | $-86.8M | $340.9M | ||
| Q3 24 | $-27.1M | $-254.2M | ||
| Q2 24 | $16.9M | $117.3M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 37.1% | ||
| Q3 25 | -7.4% | 17.0% | ||
| Q2 25 | -3.9% | 9.1% | ||
| Q1 25 | -21.2% | -25.5% | ||
| Q4 24 | -11.2% | 92.2% | ||
| Q3 24 | -3.3% | -72.3% | ||
| Q2 24 | 2.1% | 33.5% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 2.9% | ||
| Q3 25 | 16.0% | 3.5% | ||
| Q2 25 | 19.3% | 3.5% | ||
| Q1 25 | 22.7% | 2.4% | ||
| Q4 24 | 26.3% | 3.6% | ||
| Q3 24 | 23.3% | 2.1% | ||
| Q2 24 | 19.4% | 2.7% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 0.94× | ||
| Q3 25 | 2.02× | 0.50× | ||
| Q2 25 | 4.43× | 0.34× | ||
| Q1 25 | 1.37× | -1.42× | ||
| Q4 24 | 3.58× | 2.46× | ||
| Q3 24 | 2.39× | -1.72× | ||
| Q2 24 | 2.18× | 0.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
SSB
| Net Interest Income | $561.6M | 85% |
| Noninterest Income | $100.1M | 15% |
